Mutant huntingtin is present in neuronal grafts in huntington disease patients

Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain

DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J., & D, N. A. M. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,849 · see citing works

Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice

Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563 · see citing works

Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation

Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845 · see citing works

Huntington's disease: from molecular pathogenesis to clinical treatment

Ross, C. A., & Tabrizi, S. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70245-3 · Cited by 1,751 · see citing works

Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease

Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722 · see citing works

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein

Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485 · see citing works

Propagation of Tau Pathology in a Model of Early Alzheimer's Disease

de Calignon, A., Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.11.033 · Cited by 1,427 · see citing works

100 years of Lewy pathology

Goedert, M., Spillantini, M. G., Del Tredici, K., & Braak, H. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.242 · Cited by 1,190 · see citing works

The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription

Steffan, J. S., Kazantsev, A. G., Spasić-Bošković, O., Greenwald, M., Zhu, Y., Goehler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100110097 · Cited by 1,057 · see citing works

Trans-Synaptic Spread of Tau Pathology In Vivo

Liu, L., Drouet, V., Wu, J., Witter, M. P., Small, S. A., Clelland, C. L. T., & Duff, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031302 · Cited by 994 · see citing works

Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

Zuccato, C., Valenza, M., & Cattaneo, E. (2010) · Physiological Reviews · doi:10.1152/physrev.00041.2009 · Cited by 848 · see citing works

α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

Hansen, C., Angot, E., Bergström, A.-L., Steiner, J. A., Pieri, L., Paul, G., Outeiro, T. F., Melki, R., Kallunki, P., Fog, K., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43366 · Cited by 842 · see citing works

Prion-like transmission of protein aggregates in neurodegenerative diseases

Brundin, P., Melki, R., & Kopito, R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2873 · Cited by 778 · see citing works

Brain homogenates from human tauopathies induce tau inclusions in mouse brain

Clavaguera, F., Akatsu, H., Fraser, G. M., Crowther, R. A., Frank, S., Hench, J., Probst, A., Winkler, D. T., Reichwald, J., Staufenbiel, M., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301175110 · Cited by 750 · see citing works

Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length

Bêcher, M. W., Kotzuk, J. A., Sharp, A. H., Davies, S. W., Bates, G. P., Price, D. L., & Ross, C. A. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0168 · Cited by 434 · see citing works

Cytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregates

Ren, P.-H., Lauckner, J. E., Kachirskaia, I., Heuser, J. E., Melki, R., & Kopito, R. R. (2009) · Nature Cell Biology · doi:10.1038/ncb1830 · Cited by 410 · see citing works

Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis

Kennedy, L. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg352 · Cited by 384 · see citing works

Functional neuronal replacement by grafted striatal neurones in the ibotenic acid-lesioned rat striatum

Ole Isacson, A., Brundin, P., Kelly, P. A. T., Gage, F. H., & Björklund, A. (1984) · Nature · doi:10.1038/311458a0 · Cited by 300 · see citing works

Transplanted fetal striatum in Huntington's disease: Phenotypic development and lack of pathology

Freeman, T. B., Cicchetti, F., Hauser, R. A., Deacon, T. W., Li, X., Hersch, S. M., Nauert, G. M., Sanberg, P. R., Kordower, J. H., Saporta, S., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.25.13877 · Cited by 267 · see citing works

Is Parkinson's disease a prion disorder?

Olanow, C. W., & Prusiner, S. B. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906759106 · Cited by 266 · see citing works

Bilateral human fetal striatal transplantation in Huntington’s disease

Hauser, R. A., Furtado, S., Cimino, C. R., Delgado, H., Eichler, S., Schwartz, S. E., Scott, D., Nauert, G. M., Soety, E. M., Sossi, V., et al. (2002) · Neurology · doi:10.1212/wnl.58.5.687 · Cited by 245 · see citing works

Triplet repeat mutation length gains correlate with cell-type specific vulnerability in Huntington disease brain

Shelbourne, P., Keller-McGandy, C. E., Bi, W. L., Yoon, S., Dubeau, L., Veitch, N., Vonsattel, J. P., Wexler, N. S., Arnheim, N., & Augood, S. J. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddm054 · Cited by 219 · see citing works

Transmissible Proteins: Expanding the Prion Heresy

Soto, C. A. (2012) · Cell · doi:10.1016/j.cell.2012.05.007 · Cited by 210 · see citing works

Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration

Cicchetti, F., Saporta, S., Hauser, R. A., Parent, M., Saint‐Pierre, M., Sanberg, P. R., Li, X., Parker, J. R., Chu, Y., Mufson, E. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904239106 · Cited by 196 · see citing works

Anatomy and connectivity of intrastriatal striatal transplants

Wictorin, K. (1992) · Progress in Neurobiology · doi:10.1016/0301-0082(92)90044-f · Cited by 187 · see citing works

The Cellular and Subcellular Localization of Huntingtin-Associated Protein 1 (HAP1): Comparison with Huntingtin in Rat and Human

Gutekunst, C., Li, S.-H., Yi, H. L., Ferrante, R. J., Li, X., & Hersch, S. M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-19-07674.1998 · Cited by 181 · see citing works

Reversal of long-term locomotor abnormalities in the kainic acid model of huntington's disease by day 18 fetal striatal implants

Deckel, A. W., Robinson, R. G., Coyle, J. T., & Sanberg, P. R. (1983) · European Journal of Pharmacology · doi:10.1016/0014-2999(83)90150-4 · Cited by 180 · see citing works

Intrastriatal grafts derived from fetal striatal primordia. I. Phenotypy and modular organization

Graybiel, A. M., Liu, F., & Dunnett, S. B. (1989) · Journal of Neuroscience · doi:10.1523/jneurosci.09-09-03250.1989 · Cited by 170 · see citing works

Afferent and efferent connections of striatal grafts implanted into the ibotenic acid lesioned neostriatum in adult rats

Pritzel, M., Ole Isacson, A., Brundin, P., Wiklund, L., & Björklund, A. (1986) · Experimental Brain Research · doi:10.1007/bf00243834 · Cited by 167 · see citing works

Simple: A Sequential Immunoperoxidase Labeling and Erasing Method

Glass, G. F., Papin, J. A., & Mandell, J. W. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953612 · Cited by 156 · see citing works

The current clinical management of Huntington's disease

Phillips, W., Shannon, K. M., & Barker, R. A. (2008) · Movement Disorders · doi:10.1002/mds.21971 · Cited by 156 · see citing works

Generation of high‐quality protein extracts from formalin‐fixed, paraffin‐embedded tissues

Addis, M. F., Tanca, A., Pagnozzi, D., Crobu, S., Fanciulli, G., Cossu‐Rocca, P., & Uzzau, S. (2009) · PROTEOMICS · doi:10.1002/pmic.200800971 · Cited by 152 · see citing works

Rationale for intrastriatal grafting of striatal neuroblasts in patients with Huntington's disease

Peschanski, M., Césaro, P., & Hantraye, P. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00162-c · Cited by 146 · see citing works

Mutant huntingtin fragmentation in immune cells tracks Huntington’s disease progression

Weiss, A., Träger, U., Wild, E. J., Grueninger, S., Farmer, R. E., Landles, C., Scahill, R. I., Lahiri, N., Salman, H., Macdonald, D., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci64565 · Cited by 143 · see citing works

Antibody Elution Method for Multiple Immunohistochemistry on Primary Antibodies Raised in the Same Species and of the Same Subtype

Pirici, D. N., Mogoantă, L., Kumar‐Singh, S., Pirici, I., Mărgăritescu, C., Simionescu, C., & Stănescu, R. (2009) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.2009.953240 · Cited by 143 · see citing works

Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington's Disease

Bouchard, J. J., Truong, J. K., Bouchard, K. E., Dunkelberger, D. L., Desrayaud, S., Moussaoui, S. M., Tabrizi, S. J., Stella, N., & Muchowski, P. J. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4008-12.2012 · Cited by 133 · see citing works

Extracellular amyloid formation and associated pathology in neural grafts

Meyer‐Luehmann, M., Stalder, M., Herzig, M. C., Kaeser, S. A., Kohler, E., Pfeifer, M., Boncristiano, S., Mathews, P. M., Mercken, M. H., Abramowski, D., et al. (2003) · Nature Neuroscience · doi:10.1038/nn1022 · Cited by 133 · see citing works

Molecular Origin of Polyglutamine Aggregation in Neurodegenerative Diseases

Khare, S. D., Ding, F., Gwanmesia, K. N., & Dokholyan, N. V. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010030 · Cited by 106 · see citing works

Neural transplantation in Huntington disease: Long-term grafts in two patients

Keene, C. D., Sonnen, J. A., Swanson, P. D., Kopyov, O. V., Leverenz, J. B., Bird, T. D., & Montine, T. J. (2007) · Neurology · doi:10.1212/01.wnl.0000264504.14301.f5 · Cited by 101 · see citing works

Bone Marrow Transplantation Confers Modest Benefits in Mouse Models of Huntington's Disease

Kwan, W., Magnusson, A., Chou, A., Adame, A., Carson, M. J., Kohsaka, S., Masliah, E., Möller, T., Ransohoff, R., Tabrizi, S. J., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4846-11.2012 · Cited by 75 · see citing works

Intrastriatal grafts derived from fetal striatal primordia

Liu, F., Dunnett, S. B., Robertson, H. A., & Graybiel, A. M. (1991) · Experimental Brain Research · doi:10.1007/bf00231733 · Cited by 63 · see citing works

Neuronal degeneration in striatal transplants and Huntington's disease: potential mechanisms and clinical implications

Cicchetti, F., Soulet, D., & Freeman, T. B. (2011) · Brain · doi:10.1093/brain/awq328 · Cited by 59 · see citing works

Simultaneous electrophoretic analysis of proteins of very high and low molecular mass using Tris‐acetate polyacrylamide gels

Cubillos‐Rojas, M., Amair‐Pinedo, F., Tato, I., Bartrons, R., Ventura, F., & Rosa, J. L. (2010) · Electrophoresis · doi:10.1002/elps.200900657 · Cited by 54 · see citing works

Technical factors that influence neural transplant safety in Huntington's disease

Freeman, T. B., Cicchetti, F., Bachoud‐Lévi, A., & Dunnett, S. B. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.08.031 · Cited by 54 · see citing works

Neuropathology in transplants in Parkinson's disease

Brundin, P., & Kordower, J. H. (2012) · Progress in brain research · doi:10.1016/b978-0-444-59575-1.00010-7 · Cited by 51 · see citing works

Structure of Inclusions of Huntington’s Disease Brain Revealed by Synchrotron Infrared Microspectroscopy: Polymorphism and Relevance to Cytotoxicity

André, W., Sandt, C., Dumas, P., Djian, P., & Hoffner, G. (2013) · Analytical Chemistry · doi:10.1021/ac400038b · Cited by 48 · see citing works

Striatal allografts in patients with Huntington’s disease: impact of diminished astrocytes and vascularization on graft viability

Cisbani, G., Freeman, T. B., Soulet, D., Saint‐Pierre, M., Gagnon, D., Parent, M., Hauser, R. A., Barker, R. A., & Cicchetti, F. (2013) · Brain · doi:10.1093/brain/aws359 · Cited by 45 · see citing works

System-Wide Immunohistochemical Analysis of Protein Co-Localization

Kim, M., Soontornniyomkij, V., Ji, B., & Zhou, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032043 · Cited by 25 · see citing works

Review: The fate of cell grafts for the treatment of H untington's disease: the post‐mortem evidence

Cisbani, G., & Cicchetti, F. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12104 · Cited by 15 · see citing works

Blood–brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders

Sweeney, M. D., Sagare, A. P., & Zlokovic, B. V. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.188 · Cited by 3,076 · see citing works

Blood-Brain Barrier: From Physiology to Disease and Back

Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,294 · see citing works

Huntington disease

Bates, G. P., Dorsey, R., Gusella, J. F., Hayden, M. R., Kay, C., Leavitt, B. R., Nance, M., Ross, C. A., Scahill, R. I., Wetzel, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.5 · Cited by 1,641 · see citing works

Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities

Tabrizi, S. J., Flower, M. D., Ross, C. A., & Wild, E. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0389-4 · Cited by 544 · see citing works

Huntington’s Disease: Mechanisms of Pathogenesis and Therapeutic StrategiesPreprint

Jiménez-Sánchez, M., Licitra, F., Underwood, B. R., & Rubinsztein, D. C. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024240 · Cited by 512 · see citing works

Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

Jucker, M., & Walker, L. C. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0238-6 · Cited by 450 · see citing works

Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration

Goedert, M., Masuda-Suzukake, M., & Falcon, B. (2017) · Brain · doi:10.1093/brain/aww230 · Cited by 323 · see citing works

Propagation of Protein Aggregation in Neurodegenerative Diseases

Vaquer‐Alicea, J., & Diamond, M. I. (2019) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045049 · Cited by 308 · see citing works

Cerebrovascular and blood–brain barrier impairments in Huntington's disease: Potential implications for its pathophysiology

Drouin‐Ouellet, J., Sawiak, S. J., Cisbani, G., Lagacé, M., Kuan, W., Saint‐Pierre, M., Dury, R. J., Alata, W., St‐Amour, I., Mason, S. L., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24406 · Cited by 288 · see citing works

The choreography of neuroinflammation in Huntington's disease

Crotti, A., & Glass, C. K. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.04.007 · Cited by 276 · see citing works

New approaches for brain repair-from rescue to reprogramming

Barker, R. A., Götz, M., & Parmar, M. (2018) · Nature · doi:10.1038/s41586-018-0087-1 · Cited by 214 · see citing works

Clinical Features of Huntington’s Disease

Ghosh, R., & Tabrizi, S. J. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-71779-1_1 · Cited by 207 · see citing works

Human-to-mouse prion-like propagation of mutant huntingtin protein

Jeon, I., Cicchetti, F., Cisbani, G., Lee, S., Li, E., Bae, J., Lee, N., Li, L., Im, W., Kim, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1582-9 · Cited by 193 · see citing works

Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: Examples of amyloidopathies, tauopathies and synucleinopathies

Bourdenx, M., Koulakiotis, N. S., Sanoudou, D., Bézard, E., Dehay, B., & Tsarbopoulos, A. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.07.003 · Cited by 189 · see citing works

Neural stem cell therapy for neurodegenerative disorders: The role of neurotrophic support

Marsh, S. E., & Blurton-Jones, M. M. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.02.006 · Cited by 182 · see citing works

Alpha-synuclein spreading in Parkinson’s disease

Recasens, A., & Dehay, B. (2014) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2014.00159 · Cited by 179 · see citing works

Prion-like transmission of neuronal huntingtin aggregates to phagocytic glia in the Drosophila brain

Pearce, M. M. P., Spartz, E. J., Hong, W., Luo, L., & Kopito, R. R. (2015) · Nature Communications · doi:10.1038/ncomms7768 · Cited by 159 · see citing works

Axonal transport and secretion of fibrillar forms of α-synuclein, Aβ42 peptide and HTTExon 1

Brahic, M., Bousset, L., Bieri, G., Melki, R., & Gitler, A. D. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1538-0 · Cited by 162 · see citing works

Therapeutic Advances for Huntington’s Disease

Kumar, A., Kumar, V., Singh, K., Kumar, S., Kim, Y.-S., Lee, Y.-M., & Kim, J.-J. (2020) · Brain Sciences · doi:10.3390/brainsci10010043 · Cited by 166 · see citing works

Tau strains shape disease

Vaquer‐Alicea, J., Diamond, M. I., & Joachimiak, Ł. A. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02301-7 · Cited by 134 · see citing works

The role of tau in the pathological process and clinical expression of Huntington’s disease

Vuono, R., Winder‐Rhodes, S., de Silva, R., Cisbani, G., Drouin‐Ouellet, J., REGISTRY Investigators of the European Huntington’s Disease Network, Spillantini, M. G., Cicchetti, F., & Barker, R. A. (2015) · Brain · doi:10.1093/brain/awv107 · Cited by 139 · see citing works

Intercellular Spread of Protein Aggregates in Neurodegenerative Disease

Davis, A. A., Leyns, C. E. G., & Holtzman, D. M. (2018) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100617-062636 · Cited by 131 · see citing works

The prion model for progression and diversity of neurodegenerative diseases

Stopschinski, B. E., & Diamond, M. I. (2017) · The Lancet Neurology · doi:10.1016/s1474-4422(17)30037-6 · Cited by 125 · see citing works

Regulated cell death: discovery, features and implications for neurodegenerative diseases

Cui, J., Zhao, S., Li, Y., Zhang, D., Wang, B., Xie, J., & Wang, J. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00799-8 · Cited by 125 · see citing works

Huntington disease

(2018) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-63233-3.00017-8 · Cited by 122 · see citing works

Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington’s Disease: Background and Evaluation in Cell Culture

Zhang, X., Abels, E. R., Redzic, J. S., Margulis, J., Finkbeiner, S. M., & Breakefield, X. O. (2016) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-016-0350-7 · Cited by 102 · see citing works

Human Neural Stem Cell Transplantation Rescues Functional Deficits in R6/2 and Q140 Huntington's Disease Mice

Reidling, J. C., Relaño-Ginés, A., Holley, S. M., Ochaba, J., Moore, C., Fury, B., Lau, A., Tran, A. H., Yeung, S. Y., Salamati, D., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.11.005 · Cited by 98 · see citing works

Berberine: A Promising Treatment for Neurodegenerative Diseases

Cheng, Z., Kang, C., Che, S., Su, J., Sun, Q., Ge, T., Guo, Y. C., Lv, J., Sun, Z., Yang, W., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845591 · Cited by 98 · see citing works

GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington’s disease: involvement of astrocyte–neuron interactions

L’Episcopo, F., Drouin‐Ouellet, J., Tirolo, C., Pulvirenti, A., Giugno, R., Testa, N., Caniglia, S., Serapide, M. F., Cisbani, G., Barker, R., et al. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.104 · Cited by 94 · see citing works

Mutant Huntingtin Is Secreted via a Late Endosomal/Lysosomal Unconventional Secretory Pathway

Trajkovic, K., Jeong, H., & Krainc, D. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.0118-17.2017 · Cited by 85 · see citing works

N-terminal Huntingtin (Htt) phosphorylation is a molecular switch regulating Htt aggregation, helical conformation, internalization, and nuclear targeting

DeGuire, S. M., Ruggeri, F. S., Fares, M.-B., Chiki, A., Cendrowska, U., Dietler, G., & Lashuel, H. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004621 · Cited by 83 · see citing works

Rhes travels from cell to cell and transports Huntington disease protein via TNT-like protrusion

Sharma, M., & Subramaniam, S. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201807068 · Cited by 76 · see citing works

Emerging Roles of Exosomes in Huntington’s Disease

Ananbeh, H., Vodička, P., & Skalníková, H. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084085 · Cited by 82 · see citing works

Ubiquitin, Autophagy and Neurodegenerative Diseases

Watanabe, Y., Taguchi, K., & Tanaka, M. (2020) · Cells · doi:10.3390/cells9092022 · Cited by 84 · see citing works

Is Huntington's disease a tauopathy?

Gratuze, M., Cisbani, G., Cicchetti, F., & Planel, E. (2016) · Brain · doi:10.1093/brain/aww021 · Cited by 81 · see citing works

Combating Neurodegenerative Diseases with the Plant Alkaloid Berberine: Molecular Mechanisms and Therapeutic Potential

Fan, D., Liu, L., Wu, Z., & Cao, M. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180419141613 · Cited by 80 · see citing works

Dopamine and Huntington’s disease

Schwab, L. C., Garas, S. N., Drouin‐Ouellet, J., Mason, S., Stott, S., & Barker, R. A. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1025383 · Cited by 75 · see citing works

Neurons Export Extracellular Vesicles Enriched in Cysteine String Protein and Misfolded Protein Cargo

Deng, J., Koutras, C., Donnelier, J., Alshehri, M., Fotouhi, M., Girard, M., Casha, S., McPherson, P. S., Robbins, S. M., & Braun, J. E. A. (2017) · Scientific Reports · doi:10.1038/s41598-017-01115-6 · Cited by 70 · see citing works

Reactive astrocytes promote proteostasis in Huntington’s disease through the JAK2-STAT3 pathway

Abjean, L., Haim, L. B., Riquelme‐Perez, M., Gipchtein, P., Derbois, C., Palomares, M.-A., Petit, F., Hérard, A., Gaillard, M., Guillermier, M., et al. (2022) · Brain · doi:10.1093/brain/awac068 · Cited by 72 · see citing works

Ex vivo gene therapy for the treatment of neurological disorders

Gowing, G., Svendsen, S. P., & Svendsen, C. N. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.003 · Cited by 72 · see citing works

The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model

Katt, M. E., Mayo, L. N., Ellis, S., Mahairaki, V., Rothstein, J. D., Cheng, L., & Searson, P. C. (2019) · Fluids and Barriers of the CNS · doi:10.1186/s12987-019-0139-4 · Cited by 69 · see citing works

Therapeutic advances in Huntington's Disease

Shannon, K. M., & Fraint, A. (2015) · Movement Disorders · doi:10.1002/mds.26331 · Cited by 72 · see citing works

A functional scale for spinal and bulbar muscular atrophy: Cross-sectional and longitudinal study

Hashizume, A., Katsuno, M., Suzuki, K., Banno, H., Suga, N., Mano, T., Araki, A., Hijikata, Y., Grunseich, C., Kokkinis, A. D., et al. (2015) · Neuromuscular Disorders · doi:10.1016/j.nmd.2015.03.008 · Cited by 71 · see citing works

Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease

Caron, N. S., Banos, R., Yanick, C., Aly, A. E., Byrne, L. M., Smith, E. D., Xie, Y., Smith, S. E. P., Potluri, N., Findlay Black, H., et al. (2021) · The Journal of Neuroscience · doi:10.1523/jneurosci.1865-20.2020 · Cited by 66 · see citing works

Presence of tau pathology within foetal neural allografts in patients with Huntington’s and Parkinson’s disease

Cisbani, G., Maxan, A., Kordower, J. H., Planel, E., Freeman, T. B., & Cicchetti, F. (2017) · Brain · doi:10.1093/brain/awx255 · Cited by 67 · see citing works

Exosomes: Innocent Bystanders or Critical Culprits in Neurodegenerative Diseases

Beatriz, M., Vilaça, R., & Lopes, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.635104 · Cited by 65 · see citing works

Molecular mechanisms of proteinopathies across neurodegenerative disease: a review

Marsh, A. (2019) · Neurological Research and Practice · doi:10.1186/s42466-019-0039-8 · Cited by 63 · see citing works

Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington’s disease

Gratuze, M., Noël, A., Julien, C., Cisbani, G., Milot-Rousseau, P., Morin, F., Dickler, M., Goupil, C., Bezeau, F., Poitras, I., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddu456 · Cited by 65 · see citing works

Systemic manifestation and contribution of peripheral tissues to Huntington’s disease pathogenesis

Chuang, C.-L., & Demontis, F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101358 · Cited by 64 · see citing works

Demonstration of prion-like properties of mutant huntingtin fibrils in both in vitro and in vivo paradigms

Masnata, M., Sciacca, G., Maxan, A., Bousset, L., Denis, H. L., Lauruol, F., David, L. S., Saint‐Pierre, M., Kordower, J. H., Melki, R., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-01973-6 · Cited by 61 · see citing works

Research progress on the role of extracellular vesicles in neurodegenerative diseases

Li, Z., Wang, X., Wang, X., Yi, X., Wong, Y. K., Wu, J., Xie, F., Hu, D., Wang, Q., Wang, J., et al. (2023) · Translational Neurodegeneration · doi:10.1186/s40035-023-00375-9 · Cited by 65 · see citing works

Nonhuman Primate Models of Neurodegenerative Disorders

Emborg, M. E. (2017) · ILAR Journal · doi:10.1093/ilar/ilx021 · Cited by 64 · see citing works

Primary cilia and autophagic dysfunction in Huntington’s disease

Kaliszewski, M., Knott, A. B., & Bossy-Wetzel, E. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.80 · Cited by 55 · see citing works

The Cell Biology of Tau Secretion

Merezhko, M., Uronen, R., & Huttunen, H. J. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.569818 · Cited by 57 · see citing works

Huntington’s disease: the coming of age

Pandey, M., & Rajamma, U. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0957-1 · Cited by 56 · see citing works

Huntington’s disease cerebrospinal fluid seeds aggregation of mutant huntingtin

Tan, Z., Dai, W., van Erp, T. G. M., Overman, J., Demuro, A., Digman, M. A., Hatami, A., Albay, R., Sontag, E. M., Potkin, K. T., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2015.81 · Cited by 56 · see citing works

Prion-Like Characteristics of Polyglutamine-Containing ProteinsPreprint

Pearce, M. M. P., & Kopito, R. R. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a024257 · Cited by 53 · see citing works

Tissue specific microenvironments: a key tool for tissue engineering and regenerative medicine

Sachs, P. C., Mollica, P. A., & Bruno, R. D. (2017) · Journal of Biological Engineering · doi:10.1186/s13036-017-0077-0 · Cited by 51 · see citing works

S pectral‐ D omain O ptical C oherence T omography as a P otential B iomarker in H untington's D isease

Andrade, C., Beato, J. N., Monteiro, A., da Costa, A. G., Penas, S. C., Guimarães, J., Falcão‐Reis, F., & Garrett, C. (2016) · Movement Disorders · doi:10.1002/mds.26486 · Cited by 51 · see citing works

Induced Pluripotent Stem Cell-Derived Neural Stem Cell Transplantations Reduced Behavioral Deficits and Ameliorated Neuropathological Changes in YAC128 Mouse Model of Huntington's Disease

Gharaibeh, A., Culver, R., Stewart, A. N., Srinageshwar, B., Spelde, K., Frollo, L., Kolli, N., Story, D. T., Paladugu, L., Anwar, S., et al. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00628 · Cited by 50 · see citing works

Nano and microcarriers to improve stem cell behaviour for neuroregenerative medicine strategies: Application to Huntington's disease

André, E. M., Passirani, C., Seijo, B., Sánchez, A., & Montero‐Menei, C. N. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2015.12.008 · Cited by 50 · see citing works

The blood-brain barrier is disrupted in Machado-Joseph disease/spinocerebellar ataxia type 3: evidence from transgenic mice and human post-mortem samples

Lobo, D. D., Nobre, R. J., Miranda, C. O., Pereira, D., Castelhano, J., Sereno, J., Koeppen, A. H., Castelo-Branco, M. S., & de Almeida, L. P. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-00955-0 · Cited by 45 · see citing works

Cell Rearrangement and Oxidant/Antioxidant Imbalance in Huntington’s Disease

D’Egidio, F., Castelli, V., Cimini, A., & d’Angelo, M. (2023) · Antioxidants · doi:10.3390/antiox12030571 · Cited by 41 · see citing works

Neural and mesenchymal stem cells in animal models of Huntington’s disease: past experiences and future challenges

Kerkis, I., Haddad, M. S., Valverde, C. W., & Glosman, S. (2015) · Stem Cell Research & Therapy · doi:10.1186/s13287-015-0248-1 · Cited by 43 · see citing works

Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic.

Miniarikova, J., Evers, M., & Konstantinova, P. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.02.002 · Cited by 41 · see citing works

Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients

van Roon‐Mom, W., Roos, R. A. C., & de Bot, S. T. (2018) · Nucleic Acid Therapeutics · doi:10.1089/nat.2018.0720 · Cited by 41 · see citing works

Developing Stem Cell Therapies for Juvenile and Adult-Onset Huntington's Disease

Fink, K. D., Deng, P., Torrest, A., Stewart, H., Pollock, K., Gruenloh, W., Annett, G., Tempkin, T., Wheelock, V., & Nolta, J. A. (2015) · Regenerative Medicine · doi:10.2217/rme.15.25 · Cited by 41 · see citing works

Modelling and extraction of variability in free-text medication prescriptions from an anonymised primary care electronic medical record research database

Karystianis, G., Sheppard, T., Dixon, W. G., & Nenadić, G. (2015) · BMC Medical Informatics and Decision Making · doi:10.1186/s12911-016-0255-x · Cited by 41 · see citing works

Selective Neuronal Death in Neurodegenerative Diseases: The Ongoing Mystery.

Subramaniam, S. (2019) · Europe PMC (PubMed Central) · Cited by 40 · see citing works

The prion-like phenomenon in Alzheimer’s disease: Evidence of pathology transmission in humans

Gomez‐Gutierrez, R., & Morales, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009004 · Cited by 39 · see citing works

The glial response to intracerebrally delivered therapies for neurodegenerative disorders: is this a critical issue?

Cicchetti, F., & Barker, R. A. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00139 · Cited by 39 · see citing works

The Evidence for the Spread and Seeding Capacities of the Mutant Huntingtin Protein in in Vitro Systems and Their Therapeutic Implications

Masnata, M., & Cicchetti, F. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00647 · Cited by 37 · see citing works

Cell therapy in Huntington's disease: Taking stock of past studies to move the field forward

Bachoud‐Lévi, A., Massart, R., & Rosser, A. (2020) · Stem Cells · doi:10.1002/stem.3300 · Cited by 38 · see citing works

Soluble mutant huntingtin drives early human pathogenesis in Huntington’s disease

Miguez, A., Gomis, C., Vila, C., Tortajada, M., Fernández‐García, S., Bombau, G., Galofré, M., Garcı́a-Bravo, M., Sanders, P., Fernández-Medina, H., et al. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04882-w · Cited by 37 · see citing works

Huntington's disease: Current and future therapeutic prospects

Kieburtz, K. D., Reilmann, R., & Olanow, C. W. (2018) · Movement Disorders · doi:10.1002/mds.27363 · Cited by 37 · see citing works

Current and future applications of induced pluripotent stem cell-based models to study pathological proteins in neurodegenerative disorders

Jacquet, A. D. R., Denis, H. L., Cicchetti, F., & Alpaugh, M. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00999-7 · Cited by 35 · see citing works

New Directions in Therapeutics for Huntington Disease

Potkin, K. T., & Potkin, S. G. (2018) · Future Neurology · doi:10.2217/fnl-2017-0035 · Cited by 36 · see citing works

The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates

Moretto, E., Stuart, S., Surana, S., Vargas, J. N. S., & Schiavo, G. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.844211 · Cited by 32 · see citing works

Is the Immunological Response a Bottleneck for Cell Therapy in Neurodegenerative Diseases?

Salado-Manzano, C., Perpiñá, U., Straccia, M., Molina-Ruiz, F. J., Cozzi, E., Rosser, A., & Canals, J. M. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00250 · Cited by 34 · see citing works

Cell Encapsulation and 3D Bioprinting for Therapeutic Cell Transplantation

Samadi, A., Moammeri, A., Pourmadadi, M., Abbasi, P., Hosseinpour, Z., Farokh, A., Shamsabadipour, A., Heydari, M., & Mohammadi, M. R. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c01183 · Cited by 33 · see citing works

“Prion-like” seeding and propagation of oligomeric protein assemblies in neurodegenerative disorders

Zampar, S., Gregorio, S. E. D., Grimmer, G., Watts, J. C., & Ingelsson, M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1436262 · Cited by 34 · see citing works

Unconventional Secretion and Intercellular Transfer of Mutant Huntingtin

Tang, B. L. (2018) · Cells · doi:10.3390/cells7060059 · Cited by 33 · see citing works

The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1

Vieweg, S., Mahul‐Mellier, A., Ruggeri, F. S., Riguet, N., DeGuire, S. M., Chiki, A., Cendrowska, U., Dietler, G., & Lashuel, H. A. (2021) · Journal of Molecular Biology · doi:10.1016/j.jmb.2021.167222 · Cited by 33 · see citing works

Rhes protein transits from neuron to neuron and facilitates mutant huntingtin spreading in the brain

Ramírez-Jarquín, U. N., Sharma, M., Shahani, N., Li, Y., Boregowda, S. V., & Subramaniam, S. (2022) · Science Advances · doi:10.1126/sciadv.abm3877 · Cited by 32 · see citing works

Shedding a new light on Huntington’s disease: how blood can both propagate and ameliorate disease pathology

Rieux, M., Alpaugh, M., Sciacca, G., Saint‐Pierre, M., Masnata, M., Denis, H. L., Lévesque, S. A., Herrmann, F., Bazenet, C. E., Garneau, A. P., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0787-4 · Cited by 32 · see citing works

The Generation of Mouse and Human Huntington Disease iPS Cells Suitable for In vitro Studies on Huntingtin Function

Szlachcic, W. J., Wiatr, K., Trzeciak, M., Figlerowicz, M., & Figiel, M. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00253 · Cited by 30 · see citing works

From open to large-scale randomized cell transplantation trials in Huntington's disease

Bachoud‐Lévi, A. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.12.011 · Cited by 29 · see citing works

Antibody-based therapies for Huntington’s disease: current status and future directions

Denis, H. L., David, L. S., & Cicchetti, F. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104569 · Cited by 30 · see citing works

Outcome of cell suspension allografts in a patient with Huntington's disease

Maxan, A., Mason, S., Saint‐Pierre, M., Smith, E., Ho, A. K., Harrower, T., Watts, C., Tai, Y., Pavese, N., Savage, J. C., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25354 · Cited by 27 · see citing works

Human iPSC‐derived neural precursor cells differentiate into multiple cell types to delay disease progression following transplantation into YAC128 Huntington's disease mouse model

Park, H. J., Jeon, J., Choi, J., Kim, J. Y., Kim, H. S., Huh, J. Y., Goldman, S. A., & Song, J. (2021) · Cell Proliferation · doi:10.1111/cpr.13082 · Cited by 27 · see citing works

Molecular mechanisms of heterogeneous oligomerization of huntingtin proteins

Bonfanti, S., Lionetti, M. C., Fumagalli, M. R., Chirasani, V. R., Tiana, G., Dokholyan, N. V., Zapperi, S., & Porta, C. A. M. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-44151-0 · Cited by 26 · see citing works

Visualization of prion-like transfer in Huntington's disease models

Jansen, A. H. P., Batenburg, K. L., Pecho‐Vrieseling, E., & Reits, E. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.12.015 · Cited by 26 · see citing works

Passive immunization against phosphorylated tau improves features of Huntington's disease pathology

Alpaugh, M., Masnata, M., de Rus Jacquet, A., Lepinay, E., Denis, H. L., Saint-Pierre, M., Davies, P., Planel, E., & Cicchetti, F. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.01.020 · Cited by 25 · see citing works

Cell-to-cell Transmission of Polyglutamine Aggregates inC. elegans

Kim, D., Cho, K.-W., Ahn, W. J., Pérez-Acuña, D., Jeong, H., Lee, H.-J., & Lee, S. (2017) · Experimental Neurobiology · doi:10.5607/en.2017.26.6.321 · Cited by 25 · see citing works

Longitudinal imaging highlights preferential basal ganglia circuit atrophy in Huntington’s disease

Liu, C.-F., Laurent Younes, B., Tong, X. J., Hinkle, J. T., Wang, M., Phatak, S., Xu, X., Bu, X., Looi, V., Bang, J., et al. (2023) · Brain Communications · doi:10.1093/braincomms/fcad214 · Cited by 23 · see citing works

Targeting Tau to Treat Clinical Features of Huntington's Disease

Masnata, M., Salem, S., Jacquet, A. D. R., Anwer, M., & Cicchetti, F. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.580732 · Cited by 23 · see citing works

Induced Pluripotent Stem Cells in Huntington’s Disease: Disease Modeling and the Potential for Cell-Based Therapy

Liu, L., Huang, J., Han, C., Zhang, G., Xu, X., Shen, Y., Li, J., Jiang, H., Lin, Z., Xiong, N., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9601-8 · Cited by 22 · see citing works

Hunting for the cause: Evidence for prion-like mechanisms in Huntington’s disease

Donnelly, K. M., Coleman, C. M., Fuller, M. L., Reed, V. L., Smerina, D., Tomlinson, D. S., & Pearce, M. M. P. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.946822 · Cited by 20 · see citing works

Mutant huntingtin protein expression and blood–spinal cord barrier dysfunction in huntington disease

Sciacca, G., & Cicchetti, F. (2017) · Annals of Neurology · doi:10.1002/ana.25107 · Cited by 20 · see citing works

Targeted protein degradation: expanding the technology to facilitate the clearance of neurotoxic proteins in neurodegenerative diseases

Wang, X., Shuai, W., Yang, P., Liu, Y., Zhang, Y., & Wang, G. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102584 · Cited by 19 · see citing works

S4‐02‐01: Can the mutant huntingtin gene product spread from cell to cell? Evidence from neuronal allografts in huntington's disease patients

Cicchetti, F. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.07.325

Can the mutant huntingtin gene product spread from cell to cell: Evidence from neuronal allografts in Huntington's disease patients (S15.002)

Cicchetti, F., Lacroix, S., Cisbani, G., Vallières, N., Saint‐Pierre, M., St‐Amour, I., Tolouei, R., Skepper, J. N., Hauser, R. A., Mantovani, D., et al. (2015) · Neurology · doi:10.1212/wnl.84.14_supplement.s15.002 · Cited by 1 · see citing works

Mutant huntingtin can spread to allografted neurons in patients with Huntington disease

(2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.95

Evidence of mutant huntingtin and tau-related pathology within neuronal grafts in Huntington’s disease cases

Salem, S., Kilgore, M. D., Anwer, M., Maxan, A., Child, D. D., Bird, T. D., Keene, C. D., Cicchetti, F., & Latimer, C. S. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106542 · Cited by 5 · see citing works

Transneuronal propagation of mutant huntingtin contributes to non–cell autonomous pathology in neurons

Pecho‐Vrieseling, E., Rieker, C., Fuchs, S., Bleckmann, D., Esposito, M. S., Botta, P., Goldstein, C., Bernhard, M., Galimberti, I., Müller, M. M., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3761 · Cited by 185 · see citing works